hesperetin has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SJ; Shah, FH | 1 |
| Li, Q; Miao, Z; Wang, R; Yang, J; Zhang, D | 1 |
2 other study(ies) available for hesperetin and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Targeting FGL2, a molecular drug target for glioblastoma, with natural compounds through virtual screening method.
Topics: Antineoplastic Agents; Apoptosis; Betacyanins; Cell Proliferation; Computer Simulation; Diterpenes; Drug Screening Assays, Antitumor; Fibrinogen; Gene Expression Regulation; Glioblastoma; Hesperidin; Humans; Molecular Targeted Therapy; Protein Binding | 2021 |
Hesperetin Induces Apoptosis in Human Glioblastoma Cells via p38 MAPK Activation.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Hesperidin; Humans; p38 Mitogen-Activated Protein Kinases | 2020 |